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Abstract. The treatment of superficial skin lesions via daylight activated
photodynamic therapy (PDT) has been explored theoretically with three dimensional
(3D) Monte Carlo radiation transfer (MCRT) simulations. For similar parameters
and conditions, daylight activated PDT was compared to conventional PDT using
a commercially available light source. Under reasonable assumptions for the optical
properties of the tissue, protoporphyrin IX (PpIX) concentration, and a treatment dose
of 75 J cm−2, it was found that during a clear summer day an effective treatment depth
of over 2 mm can be achieved after 30 min of daylight illumination at a latitude of 56
degrees North. The same light dose would require 2.5 h of daylight illumination during
an overcast summer day where a treatment depth of about 2 mm can be achieved. For
conventional PDT the developed model suggests that 15 min of illumination is required
to deliver a light dose of 75 Jcm−2, which would result in an effective treatment depth
of about 3 mm. The model developed here allows for the determination of photo-
toxicity in skin tissue as a function of depth for different weather conditions as well as
for conventional light sources. Our theoretical investigation supports clinical studies
and shows that daylight activated PDT has the potential for treating superficial skin
lesions during different weather conditions.
1. Introduction and Background
Photodynamic therapy (PDT) relies on the interaction between light, molecular oxygen
and a photosensitive chemical to produce singlet oxygen and other reactive oxygen
species (ROS), leading to tissue injury and death of targeted cells (Henderson and
Dougherty, 1992; Castano et al., 2004). PDT is an efficient treatment method and is
commonly used to treat non melanoma skin cancers (NMSC) and precancerous lesions
such as aktinic keratosis (AKs) (Wilson and Patterson, 2008). However, PDT is often
associated with pain during light illumination (Castano et al., 2004). The prodrug
5-aminolaevulinic acid (ALA) or its methyl ester, methyl aminolevulinate (MAL) is
2administered topically in the form of a cream. The drug then diffuses through the skin
and is converted (at a higher rate by the lesional cells) to the photosensitive chemical
protoporhyrin IX (PpIX) via the heme biosynthetic pathway (Wachowska et al., 2011;
Darlenski and Fluhr, 2012), resulting in a high accumulation and localisation of PpIX
in the affected lesional areas.
PpIX absorbs light over a wide range of the visible spectrum and therefore a
large range of different artificial light sources are suitable for treatment. Daylight-
PDT removes the need for artificial light sources, results in less pain during treatment
(Cottrell et al., 2008), and in clinical studies was the preferred choice of treatment
for many patients (Wiegell et al., 2008). In addition to the reduced pain, patients
were found to have equally efficient treatment outcomes compared to conventional PDT
(Wiegell et al., 2008, 2012, 2013b, 2011b,a, 2013a, 2009). Another benefit of daylight
PDT is that it is not limited by the size of the lesion, allowing larger areas to be treated
simultaneously, thus reducing the required number of treatments for many patients.
However, to continue to optimise the treatment parameters it is important to develop
an appropriate approach to modelling daylight PDT.
To our knowledge, there have not been any theoretical investigations of daylight
PDT and in this paper we present results from a 3D Monte Carlo Radiation Transfer
(MCRT) model which simulates daylight PDT and investigates its potential and
limitations. MCRT is a fast and accurate method for simulating the propagation of
photons through a highly scattering medium and has, over the last two decades, become
a popular technique to study the passage of light through skin tissue for a wide range
of biomedical applications (Binzoni et al., 2008; Zhu and Liu, 2013; Swartling et al.,
2003; Prahl et al., 1989). The code used to generate the presented results was adapted
from a publically available code and was written in FORTRAN 77 (Wood, 2013) . The
methods used in this work allow us to determine the photo-toxicity at different depths
in the simulated skin and tumour tissue for different light sources and, in the case of
daylight PDT, for different weather conditions.
The model adopts the same conditions for daylight PDT as for conventional PDT,
where the PpIX is already accumulated before the tissue is exposed to light. The purpose
of this simulation is to investigate daylight as a potential light source for PDT treatment
keeping all other parameters the same as for conventional PDT.
2. Methods
MCRT is a numerical technique that uses the probabilistic nature of photon interactions
to simulate the transport, scattering and absorption of light in highly scattering media.
Photons from natural or artificial light sources enter skin and travel a distance to an
interaction location that is determined by the scattering and absorption coefficients of
that tissue type. The probability of photons being scattered is determined by the ratio
µs/(µa + µs), where µs is the scattering coefficient and µa is the absorption coefficient
(Prahl et al., 1989; Swartling et al., 2003; Premru et al., 2013). The MCRT code that
3has been used in this work was originally developed for astronomy research (Wood and
R. J. Reynolds, 1999) but was adapted and validated for skin tissue phantoms and PDT
treatment simulations (Valentine et al., 2013, 2011).
Although the initial setup adopts tissue parameters that are uniform throughout
the modelled region, MCRT was used (instead of analytic radiation transfer techniques)
since photobleaching results in a non-uniform distribution of PpIX during the time
dependent simulations.
2.1. Optical Properties
The MCRT code developed here can incorporate optical properties for different types
of tissue, determined from theory or experiment. For the simulations presented in this
paper, the wavelength dependent scattering (µs) and absorption coefficients (µa) for
skin tissue and tumour tissue shown in figure 1 were adopted (Salomatina et al., 2006;
Yudovsky and Pilon, 2010, 2011) . Many studies report a wide range of values for the
optical properties of human skin and are summarised in recent review papers by Lister
et al (Lister et al., 2012) and Jacques (Jacques, 2013).
In this work, the model developed by Yudovsky et al (Yudovsky and Pilon, 2010,
2011) was employed. This model is based on in vivo measurements, and determines
the optical properties for healthy skin tissue over the wavelength range required for
daylight PDT modelling. The scattering coefficients for the tumour tissue (nodular
basal cell carcinoma, nBCC) were taken from the model developed by Jacques which is
based on the data from Salomatina et al (Jacques, 2013; Salomatina et al., 2006). The
absorption coefficients for the tumour tissue are based on data determined by in vitro
measurements of nBCC (Salomatina et al., 2006).
The angular scattering phase function was modelled using the Heyney-Greenstein
phase function (Prahl et al., 1989; Henyey and Greenstein, 1941; Jacques et al., 1987;
Van Gemert et al., 1989),
HG(θ) =
1
4pi
1− g2
(1 + g2 − 2g cos θ)3/2 (1)
where θ is the scattering angle and g is the anisotropy factor which is in the range
−1 ≤ g ≤ 1, with g = 0 for isotropic scattering. For skin tissue, the scattering processes
are very forward directed and we adopted a wavelength dependent anisotropy factor
(Van Gemert et al., 1989), g = 0.62 + 0.29 × 10−3λ, where λ is the wavelength in
nm. Polarisation is not considered and the reflectance at the air/tissue interface was
determined using Fresnel reflectance assuming a uniform refractive index of 1.38 for the
skin surface.
The absorption properties of PpIX affect the photodynamic dose and thus the
efficacy of different PDT treatments. The wavelength dependent absorption of the
photosensitive chemical PpIX is shown in figure 2 (Valentine et al., 2011, 2013; Valentine,
2011).
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Figure 1. Wavelength dependent optical properties of tumour and skin tissue. The
black curves correspond to the scattering coefficients (solid line corresponds to healthy
skin tissue and dashed line corresponds to nodular BCC tissue). The red curves, plotted
on the right axis, indicate the absorption coefficients for both healthy and nodular BCC
tissue. The optical properties for healthy skin tissue are based on a modelling approach
developed by Yudovsky et al (Yudovsky and Pilon, 2010, 2011) which takes into
account different contributions of different chromophores. The scattering coefficients
for tumour tissue are based on the interpolation of data extracted from Salomatina et
al (Salomatina et al., 2006) using the approach developed by Jacques (Jacques, 2013)
2.2. Some Code Details
The MCRT code tracks power packets (hereafter referred to as “photons”) on their
random walk through a 3D linear cartesian grid. The source power is split among N
Monte Carlo packets so that each packet has a radiant power given by P/N, where P is
the source power (W). The optical properties can be changed for each individual grid
cell, allowing for light propagation to be studied in complex 3D structures. In this study
a cylindrical tumour surrounded by healthy tissue was investigated. The tumour was
assumed to have a diameter of 6 mm and was positioned in the middle of a cartesian grid
with dimension 10mm x 10mm x 10mm. Repeated boundary conditions were adopted,
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Figure 2. Absorption coefficient of PpIX. The absorption coefficient is concentration
dependent and for this simulation we assume an initial number density of PpIX
molecules of 1.62× 1014 cm−3.(Valentine, 2011; Valentine et al., 2013)
where photons that escape out of the sides of the grid continued in the same trajectory
from the opposite side. The tissue outside of the tumour was assumed to be of a single
tissue type (dermis) with a smooth uniform structure with different optical properties
compared to the tumour. The PpIX was also assumed to have a uniform distribution
within the cylindrical tumour.
Source photons were launched from the top of the grid and assigned an initial
direction and wavelength depending on the source being simulated (e.g. daylight or an
artificial light source). They were followed until they were either absorbed or scattered
out of the simulation grid (figure 3). Absorbed photons could be re-emitted at a
different wavelength as fluorescent emission (Swartling et al., 2003; Valentine et al., 2011;
Farrell et al., 1998). A time dynamic was added to the code to take into account the
photobleaching that changes the spatial distribution of PpIX throughout the treatment.
At each time step 5×106 photons were launched and the photobleaching was determined
before the simulated time was increased and the process was repeated.
6Photobleaching depends on the fluence rate as well as the initial PpIX concentration
(Jacques et al., 1993; Farrell et al., 1998; Robinson et al., 1998; Valentine et al., 2011;
Jongen and Sterenborg, 1997) and is described by,
C(x, y, z, t) = C0(x, y, z)e
−Ψ(x,y,z)t/β(λ) (2)
where C(x, y, z, t) is the time dependent PpIX concentration at location (x, y, z) at
time t, C0(x, y, z) is the initial concentration, and Ψ(x, y, z) is the local fluence rate
in Wcm−2. The fluence rate was updated at each time step to take into account the
change in PpIX concentration due to photobleaching. The motivation for generating a
time dependent MCRT model is that the concentration of PpIX, which changes with
time, affects the photodynamic dose (PDD).
The photobleaching constant, β, is defined as the light dose (Jcm−2) required to
reduce the fluorescence signal from the photosensitiser by 37% (1/e). The value for
β has previously been established to be 14 Jcm−2 for 630 nm irradiation (Valentine
et al., 2011). However, research by other groups indicates that the photobleaching rate
is wavelength dependent (Jacques et al., 1993; Nadeau et al., 2004). Hence, for daylight
PDT, a wavelength dependent photobleaching constant has to be adopted. To our
knowledge there is no information about how the photobleaching constant changes with
wavelength. The assumption that has been made is that β is inversely proportional to
the absorption of the photosensitizer. This allows the photobleaching equation to include
the difference in absorption for different wavelengths and to account for the different
energies carried by photons of different wavelengths. Since we only have clinical data
verifying the photobleaching constant at 630 nm, for the simulations presented here the
following wavelength dependence was applied to the photobleaching constant
β(λ) =
β630 µa630 630
λ µaλ
(3)
where β630 = 14 J cm
−2 (clinically determined (Valentine et al., 2011)), µa630 is
the absorption coefficient of PpIX at 630 nm, λ is the wavelength of the simulated
photon in nm and µaλ is the absorption coefficient for PpIX at that wavelength.
The photobleaching equation (Valentine et al., 2011; Jacques et al., 1993) assumes an
exponential decay and an unlimited oxygen supply.
The PDD was calculated in the model and is defined as the number of photons
absorbed by the photosensitiser, per cubic centimetre (Jacques et al., 1993). Following
the method by Farrell et al (Farrell et al., 1998) the PDD was assumed to be proportional
to the production of singlet oxygen. A toxic threshold determines the limit of the number
of photons that have to be absorbed for necrosis to occur and has previously (Patterson
et al., 1990) been found to be 8.6 × 1017 photons cm−3. Although this threshold
is based on measurements of Photofrin in liver tissue it was adopted for illustrative
purposes, allowing for comparison with previously published models (Jacques et al.,
1993; Valentine et al., 2011).
In the Monte Carlo model developed here, the wavelengths of the incident photons
were chosen such that the probability distribution function of the irradiance, and
7therefore the daylight and Aktilite spectra, are reproduced. As the photons are tracked
on their random walks within the model, they contribute to counters that contain the
total fluence rate and PDD, which are output after each time step. The code was
thoroughly verified and a more detailed description of the code and its validation can
be found elsewhere (Valentine et al., 2013, 2011; Wood and R. J. Reynolds, 1999).
Figure 3. The MCRT simulation employs a 3D cartesian grid (100 grid cells on a
side) which is illuminated from above. The optical properties are determined in each
individual grid cell. A cylindrical tumour is added in the centre of the grid, where the
PpIX is accumulated and assumed to be of uniform density. The dimensions of the
grid are 10mm on a side and the tumour diameter is 6mm.
2.3. Natural and Artificial Light Sources
The light distribution under the surface of the skin depends on the incident light field
which in the case of daylight PDT consists of both direct and diffuse sunlight (figure 4).
Due to the differences of the spectral and angular illumination between the diffuse and
the direct light, it is important to decompose their relative contributions (Usami and
Kawasaki, 2012). The light distribution also depends on weather conditions, time of the
day and month of the year (Bird and Riordan, 1986). In the simulations it was assumed
that the direct sunlight enters the skin at a constant angle depending on the latitude
on Earth. The diffuse radiation, which we assumed illuminates the skin isotropically,
comprises sunlight that has been scattered by molecules and particles in the atmosphere
and reaches the surface of the Earth. The intensity of daylight is often measured in lux
and is referred to as illuminance which is a measure of the irradiance weighted by the
luminosity function, which takes into account the sensitivity of the human eye. The
illuminance for daylight (at midday) varies from about 120 000 lux for a very clear
sunny day to around 20 000 lux for an overcast day during summer, to considerably
lower (<7500 lux) in the middle of winter (overcast) (Wiegell et al., 2012). In this study
we considered weather conditions in the middle of summer where the solar zenith angle
8Figure 4. Daylight consists of both direct and diffuse light. Direct photons in the
MCRT simulation are assigned a single angle of incidence. Diffuse light isotropically
illuminates the surface of the skin phantom and consists of photons that have been
scattered from particles and aerosols in the atmosphere. On sunny days the proportion
of direct light will be larger and on an overcast day 100% of the daylight is assumed
to be diffuse light.
was assumed to be 30◦ at 56 degrees North (Van Heuklon, 1979), appropriate for the
latitudes of Copenhagen in Denmark and Dundee in Scotland.
The direct and diffuse spectra used in the simulations were generated from a model
of the solar spectrum reaching Earth (Bird and Riordan, 1986). The total spectral
irradiance ITλ at wavelength λ, incident on a horizontal surface is given by,
ITλ = Idλ cos θ + Isλ (4)
where Idλ and Isλ are the direct and diffuse (scattered) contributions, and θ is the angle
from the normal to the surface to the incident light. The direct component is dependent
on the solar zenith angle and is expressed by,
Idλ = HoλDTrλ Taλ Twλ Toλ Tuλ (5)
where Hoλ is the extraterrestrial irradiance at the mean sun-earth distance. D is the
correction parameter that takes into account the distance between the sun and the
earth which depends on the day of the year. The remaining components correspond
to transmittance function of the atmosphere at different wavelengths. Trλ takes into
account the molecular or Rayleigh scattering, Taλ the aerosol attenuation, Twλ the water
vapour absorption, Toλ the ozone absorption and Tuλ takes into account the uniform
mixed gas absorption.
The contribution from diffuse sunlight is
Isλ = Irλ + Iaλ + Igλ (6)
where Irλ is the Rayleigh scattering component, Iaλ is the contribution from aerosol
scattering, and the third component, Igλ, takes into account the reflection of sunlight
between the ground and the air. A more detailed description of the algorithm and model
9can be found in Bird et al (1986) (Bird and Riordan, 1986). The exposure will vary
between different people and different body sites (Diffey, 2008; Schauberger, 1990). To
take this into account different surface orientations were investigated which will alter
the intensity of the irradiance according to equation 4.
The direct and diffuse spectra that were input to the Monte Carlo simulations
(figure 5) represent conditions for midday on a clear summer day. The spectra are
generated with a resolution of 5nm. In this model the direct light represents 80% of the
total illuminance of about 100 000 lux. For daylight PDT simulations of an overcast
day, the spectrum was assumed to be 100% diffuse light, corresponding to about 15
000 lux. Daylight PDT was compared to conventional PDT by simulating illumination
by an Aktilite lamp (Photocure ASA, Hoffsveien 48, N-0377 Oslo, Norway) (Moseley,
2005) which is a red LED light source, typically used for conventional PDT treatment.
The spectral irradiance for the Aktilite is plotted in figure 5. Also shown in figure 5
is the spectral shape of the PpIX absorption spectrum, showing the strong absorption
around 400 nm and the smaller absorption peak coincident with the Aktilite spectrum.
3. Results for Monte Carlo Modelling of daylight PDT
Daylight may be absorbed by PpIX over a wide wavelength range, while the Aktilite
targets the smaller PpIX absorption peak around 630 nm (figure 5). This means that
the total absorbed energy (by PpIX) is roughly 5 times greater for daylight compared to
the Aktilite . The conventional treatment light source targets the PpIX absorption peak
at 630 nm because of the deeper penetration depths attainable by long wavelength light
(Richards-Kortum and Sevick-Muraca, 1996). The dominant absorbing wavelengths
for daylight and conventional PDT are 405 nm and 630 nm respectively and in figure
6 results of two separate Monte Carlo simulations for the PDD assuming normal
illumination by monochromatic light at 405 nm and 630 nm are shown. Results are
displayed for four different light doses of 10, 20, 40 and 75 Jcm−2. As one would expect,
due to the deeper penetration, the 630 nm light achieves higher PDD at greater depths
compared to the 405 nm light. Although not penetrating to as great a depth, the 405
nm light achieves the same PDD at superficial layers.
The results of Monte Carlo simulations of the depth dependent PDD using the
daylight spectrum (on clear and overcast days) and Aktilite are shown in figure 7 for
light doses of 10 and 75 Jcm−2, with a PpIX absorption coefficient at 630nm obtained
from figure 2 of 0.06 cm−1. To investigate the full range of published values (Farrell
et al., 1998), a higher and lower PpIX concentration were also investigated. Figures 8
and 9 show the resulting PDD for daylight PDT when the PpIX absorption coefficients
at 630 nm are 0.18 cm−1 and 0.02 cm−1, representing higher and lower concentrations
of PpIX compared to the results in figure 7.
Figure 6 - 8 show simulations for the case when direct daylight is incident at θ = 30◦
from the normal to the skin surface. The results of different surface orientations are
shown in figure 10. For the clear daylight situation the PDD has been simulated for θ in
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Figure 5. Illuminating spectra adopted for our MCRT simulations for daylight (Bird
and Riordan, 1986) and the Aktilite (Moseley, 2005). The indicative absorption curve
for PpIX is shown in blue and is provided as a guide to the eye only to highlight
the dominant absorbing features. The Aktilite spectrum targets a small absorption
peak around 630nm while the daylight utilises the whole absorption spectrum of PpIX
which results in more energy being absorbed from the daylight even though the spectral
irradiance is lower.
equation 4, of 0◦, 60◦ and 80◦. All the situations investigated assumed that the patient
would orient the lesion being treated towards the sun.
4. Discussion
Due to the Soret band of PpIX (the broad absorption around 400nm in figure 2)
and limited penetration depth at these wavelengths, the daylight will contribute to
a larger accumulated PDD closer to the surface. This results in rapid photobleaching
at the beginning of the treatment that then slows as treatment progresses since the
concentration of PpIX is reduced. Figure 7 indicates that on a clear sunny day it would
take about 30 minutes to deliver a light dose of 75 Jcm−2 with an effective treatment
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Figure 6. Photodynamic dose for two separate wavelengths at normal incidence on
the tumour. Four different light doses are plotted, 10, 20, 40 and 75 Jcm−2, where
both light sources are assumed to have an irradiance of 82 mWcm−2. The horizontal
line corresponds to the toxic threshold which determines the number of photons that
have to be absorbed for necrosis to occur.
depth of over 2 mm. The same light dose would take about 2.5 h to deliver on an overcast
day with approximately the same effective treatment depth. The Aktilite delivers the
same light dose after about 15 min of irradiation, yielding an effective treatment depth
of about 3 mm. It is clear from figure 7 that the treatment depth is limited by the
light penetration. Even though a longer treatment time results in deeper treatment,
this requires sufficient amount of PpIX and light.
The skin phantom we adopt is a simplified model, where the well defined layered
structure has not been taken into account. The shape of the tumour is not an exact
replica of those found in patients but shows the discrepancy between healthy tissue and
diseased tissue. The optical properties are assumed to be uniform within the tissue
and future developments could include different structures such as blood vessels that
may affect the spatial distribution of absorbers and scatterers (Finlay and Foster, 2004;
Rajaram et al., 2010).
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Figure 7. Photodynamic dose for conventional PDT treatment (red), and for daylight
PDT for both a clear summer day (solid black) as well as an overcast summer day
(dashed black). The photodynamic dose is plotted for two light doses, 10 and 75
Jcm−2. The irradiance for the Aktilite is assumed to be 82 mWcm−2, while the
irradiance for a clear summer day is determined to be 41 mWcm−2 and for an overcast
summer day the irradiance is determined to be 8 mWcm−2. Corresponding treatment
times are displayed in the plot.
A further complication in clinical treatment is the time dependent build up of PpIX
prior to the commencement of irradiation. In this work a uniform distribution of PpIX
was assumed, although treatment depth may also be limited by the distribution of PpIX
(Svaasand et al., 1996; Star et al., 2002).
Even though studies have shown that oxygen is depleted during treatment, the
model presented here assumes an unlimited oxygen supply. To accurately take into
account the oxygen supply (Tyrrell et al., 2011; Liu et al., 2010; Henderson et al.,
2000) both oxygen consumption as well as perfusion would have to be considered. This
phenomenon is not well understood and further investigation is required (Tyrrell et al.,
2011).
It is well known that optical properties vary for patients with different skin types
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Figure 8. Photodynamic dose for the situation where the concentration of PpIX has
been increased by a factor of three. This corresponds to an absorption coefficient at
630 nm for PpIX of 0.18 cm−1. Light doses of 10 and 75 Jcm−2 are plotted and
correspond to the same treatment times as indicated in figure 7.
and may be a reason for the different treatment outcomes. In our simulations, apart from
the time dependent effects of photobleaching on the concentration of PpIX, all other
optical properties remain constant during treatment. Other effects such as heating and
oxygen consumption during treatment may change the optical properties and affect the
treatment depth.
It is clear from figure 8 and 9 that the concentration, and therefore the uptake and
accumulation of PpIX in the tumour, will have a large effect on the treatment outcome.
Fewer available PpIX molecules will restrict the photon absorption but will also result in
slower photobleaching. The absorption of PpIX will lead to generation of toxic oxygen
species, hence the initial PpIX concentration may affect the treatment outcome as well.
Fluorescence is a quantity that can be used to determine the relative concentration
of PpIX. This has been studied by Valentine et al (Valentine et al., 2013; Valentine,
2011), showing that the initial fluorescent signal varies dramatically among patients,
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Figure 9. Photodynamic dose for the situation where the concentration of PpIX has
been reduced by a factor of three. This corresponds to an absorption coefficient at
630nm for PpIX of 0.02 cm−1. The light doses and treatment times are equivalent to
those plotted in figure 7 and 8.
suggesting that the uptake and accumulation of PpIX within the tumour will also be
different from patient to patient.
A patient undergoing daylight PDT will not constantly orient the area of interest
perpendicular to the direct sunlight since this will sometimes be inconvenient. Figure
10 shows that a steeper angle to the sun results in a lower irradiance and therefore a
slightly lower effective penetration depth of the treatment light.
Although there are more complicated descriptions of photobleaching (Georgakoudi
and Foster, 1998), the photobleaching equation that has previously been applied in the
group was also adopted here (Valentine et al., 2013). However a modification to this
equation was made where the PpIX absorption was included as well as a time-dependent
fluence rate. For previously modelled photobleaching, where similar equations have been
adopted, the photobleaching is only dependent on the local fluence rate as well as time.
By including a wavelength dependent β, the photobleaching is not only dependent on
15
e = 0 degrees
e = 30 degrees
e = 60 degress
e = 80 degrees
0 1 2 3 4 5
Depth [mm]
0.1
1.0
10.0
Ph
ot
od
yn
am
ic 
Do
se
 [1
01
8  p
ho
to
ns
 /c
m
3 ]
Figure 10. Effect of different illumination angles. The four different angles that have
been investigated are θ = 0◦, 30◦, 60◦, and 80◦, where θ is the angle between the
incident light and the normal to the surface. In each case it is assumed that the person
being exposed to daylight faces the sun.
time, but also depends on the absorption of PpIX. This ensures that when the PpIX
is fully photobleached, the number of absorbed photons is the same, independent of
irradiance and wavelength. This would not be the case for a wavelength independent
value for β.
5. Conclusions
We have developed a MCRT model for the simulation of conventional and daylight
activated PDT. It was used to investigate the potential and limitations of treating
superficial skin lesions with artificial and natural light. The model determines the
toxicity (PDD) within the tumour as a function of depth during different weather
conditions. Adopting optical properties appropriate for healthy and diseased tissue,
simulations show that for a clear summer day it would take around 30 minutes to deliver
a light dose of 17 Jcm−2, which is comparable to the light dose used in conventional
16
PDT treatments. The simulations predict an effective treatment depth for daylight PDT
of over 2 mm, making it ideal for treating superficial skin lesions, though limiting its
efficacy for deeper lying tumours. The effect of PpIX concentration was also investigated,
finding that a higher concentration yields a greater effective penetration depth. The
results of our MCRT simulations support the clinical findings that daylight PDT can
be an effective alternative to conventional PDT for appropriate tumour types.
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